Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q2 2020 Earnings Conference Call August 7, 2020 9:00 AM ET Company Participants Thomas Gad - Founder, Chairman, President & Head, Business Development & Strategy Claus Moller - Chief Executive Officer Bo Kruse - Executive Vice President & Chief Financial Office Conference Call Participants Alec Stranahan - Bank of America Merrill Lynch Etzer Darout - Guggenheim Securities, LLC Robert Burns - H.C. Wainwright & Co., LLC David Lebowitz - Morgan Stanley Peter Lawson - Bar ...

mAbs herapeutics, Inc. Company Presentation August 2020 Disclaimer This presentation contains forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995. The forward-looking statements involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans and ...

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2020 Earnings Conference Call May 8, 2020 9:00 AM ET Company Participants Thomas Gad - Founder, Chairman and President and Head of Business Development and Strategy Claus Moller - Chief Executive Officer Bo Kruse - Executive Vice President and Chief Financial Office Conference Call Participants Alec Stranahan - Bank of America Merrill Lynch Etzer Darout - Guggenheim Securities, LLC Robert Burns - H.C. Wainwright & Co., LLC David Lebowitz - Morgan Stanley Boris Peak ...

mAbs herapeutics, Inc. Company Presentation May 2020 Disclaimer This presentation contains forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995. The forward-looking statements involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans and obj ...

mAbs herapeutics, Inc. Company Presentation March 2020 Disclaimer This presentation contains forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995. The forward-looking statements involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans and o ...